Department of Veterans Affairs Awarded a Contract to KINIKSA PHARMACEUTICALS (UK), LTD. for $34,022.62

Q: Where is KINIKSA PHARMACEUTICALS (UK), LTD. located?

THIRD FLOOR LONDON UNITED KINGDOM

Signed on

1/31/2026, 12:00 AM

KINIKSA PHARMACEUTICALS (UK), LTD. Government Contract #36C24526N0294

KINIKSA PHARMACEUTICALS (UK), LTD. was awarded a contract with the United States Government for $34,022.62. The contract was awarded by the agency office 245-NETWORK CONTRACT OFFICE 5 (36C245), which is a division with the Department of Veterans Affairs within the Department of Veterans Affairs.

Summary of Award

The recipient of the federal contract is Kiniksa Pharmaceuticals (UK), Ltd., a company based in London, United Kingdom. The contract, awarded by the Department of Veterans Affairs, is for the supply of ARCALYST 200 MG drugs, totaling $34,022.62. The contract was awarded through a delivery order with only one offer received, and it involved full and open competition. The contract was issued on January 31, 2026, with no subsidy cost involved.

Contract Details

Contract ID36C24526N0294

Contract TypeC

Total Obligation$34,022.62

Exercised Options$34,022.62

Base Amount + Options$34,022.62

Date Signed2026-01-31

Contract DescriptionARCALYST 200 MG

Start Date2026-01-31

End Date2026-02-04

Agency Details

Awarding AgencyDepartment of Veterans Affairs

Awarding Sub AgencyDepartment of Veterans Affairs

Awarding Office245-NETWORK CONTRACT OFFICE 5 (36C245)

Funding AgencyDepartment of Veterans Affairs

Funding Sub AgencyDepartment of Veterans Affairs

Funding Office688-WASHINGTON DC (00688)(36C688)

Recipient Details

RecipientKINIKSA PHARMACEUTICALS (UK), LTD.

Recipient LocationTHIRD FLOOR LONDON , UNITED KINGDOM

Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Foreign Owned, Not Designated a Small Business, Special Designations

Comments

Award Transactions

Transaction #0 | $34,022.62January 31, 2026

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $34,022.62 to KINIKSA PHARMACEUTICALS (UK), LTD.. The payment included a Subsidy Cost of $0.00.